Driven by Science.

𝗠𝗲𝗲𝘁 𝗘𝗵𝘂𝗱 𝗥𝗮𝗶𝘃𝗶𝘁𝘇 — 𝗖𝗘𝗢 𝗼𝗳 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
With three decades of leadership in the medical device and pharmaceutical industries, Ehud Raivitz has built a career on driving innovation, scaling businesses, and forging international partnerships. From leading startup ventures to steering strategic M&A, his expertise spans product development, regulatory strategy, and global commercialization.
As CEO of Cogniguard, Ehud brings together diverse cultures, talents, and ideas to guide the strategic path for bringing Vguard’s groundbreaking technology to market.
Recognized with the Industry Award from the Manufacturers Association of Israel for Elcam Medical’s exceptional growth and leadership, Ehud continues to champion innovation that makes a global impact.

𝗠𝗲𝗲𝘁 𝗔𝗱𝗮𝗺 𝗕𝗿𝗼𝗻𝗰𝗲𝗹 𝗠𝗗, 𝗣𝗵𝗗— 𝗖𝗵𝗶𝗲𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 𝗮𝘁 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
Physician. Entrepreneur. Clinical researcher.
For over two decades, Dr. Adam Broncel has been working at the intersection of neurology and biomedical innovation, turning scientific discoveries into solutions that improve patients’ lives.
With a medical degree, a Ph.D. in neuromodulation, and international research experience in the USA and Europe, he has dedicated much of his career to exploring the power of vagus nerve stimulation. His research has been published in leading journals (Brain Research, PLOS, Neuroscience) and presented at major neurological congresses, from Helsinki to Amsterdam.
As an entrepreneur, he co-founded Biomed Innovation and Poland Ventures, building ecosystems that help international startups thrive. He has scaled ventures across borders, secured EU grants, and co-invented patents in neuromodulation. He also advises global initiatives and has represented Poland at MIT and other leading U.S. innovation hubs.
At Cogniguard, Dr. Adam Broncel serves as Chief Medical Officer and board member, leading our Polish branch. He designed and oversaw preclinical studies and the very first proof-of-concept trials of the Vguard method — and is now spearheading upcoming multicenter clinical trials in Europe and the U.S. His role bridges science, clinical development, and investor engagement, all with a single purpose: to bring breakthrough therapies for Alzheimer’s and cognitive decline to patients.
What motivates him most?
“The opportunity to turn scientific innovation into real solutions for devastating conditions like Alzheimer’s. Knowing that our work can change patients’ lives gives me purpose every single day.”
One achievement he’s especially proud of:
Leading the first human trials of the Vguard method, witnessing years of research come to life in patients, and seeing early signs of positive impact on memory and cognition.

𝗠𝗲𝗲𝘁 𝗗𝗿. 𝗠𝗮𝗴𝗱𝗮𝗹𝗲𝗻𝗮 𝗞𝗿𝗮𝘄𝗰𝘇𝘆𝗸 — 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗖𝗼𝗼𝗿𝗱𝗶𝗻𝗮𝘁𝗼𝗿 𝗮𝘁 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
Magdalena brings over 16 years of experience at the intersection of psychology, psychotherapy, and clinical research. With a Ph.D. in Medical Sciences and a career spanning both hospital care and academic research, she has dedicated her work to understanding and supporting patients with cognitive decline, depression, anxiety, psychosomatic conditions, and memory disorders following strokes, heart disease, or cancer treatment.
At Cogniguard, Magdalena plays a pivotal role as Clinical Trials Coordinator, leading studies in Poland and Israel from start to finish — designing protocols, recruiting and guiding patients, assessing cognitive function, managing data, and preparing scientific publications and conference presentations. She was deeply involved in the company’s first clinical trials of its breakthrough vagus nerve stimulation technology and continues to drive new studies that bring us closer to transforming the future of Alzheimer’s therapy.
What she values most is working on innovations that help patients preserve memory and independence — restoring the role of memory as a bridge between generations.
Her proudest professional milestone has been combining clinical practice with scientific passion: earning her Ph.D., contributing to international research, and helping build methods that may one day change the lives of patients and families affected by Alzheimer’s.

𝗠𝗲𝗲𝘁 𝗗𝗿. 𝗕𝗲𝗻 𝗗𝗮𝘃𝗶𝗱 — 𝗙𝗼𝘂𝗻𝗱𝗲𝗿 & 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗼𝗳 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
With 27 years of management and entrepreneurship experience — including 25 years leading innovation in the medical device industry — Tamir Ben David has dedicated his career to advancing healthcare through breakthrough technologies. He has served in leadership roles as CEO, President, GM, Division VP, and VP of Business Development, while also founding five medical device companies and a medical innovation hub spanning neurology, cardiology, femtech, minimally invasive surgery, and orthopedics.
An inventor at heart, Dr. Ben David holds more than 100 patent families covering implantable devices, nerve and tissue stimulation, signal processing, diagnostic algorithms, control systems, and video platforms. He earned his Ph.D. (Cum Laude) in Physics and an MBA from TLV University.
At Cogniguard, Dr. Ben David is both the founder and inventor of the company’s core technology and IP. Today, he serves as President, supporting the company’s intellectual property and business strategy while working closely with a passionate, professional team committed to bringing the best solutions to market.
What motivates him now is the opportunity to deliver game-changing solutions for cognitive decline and other clinical challenges by harnessing the natural power of the vagus nerve.
Beyond the lab and boardroom, Dr. Ben David has led an eclectic journey: from nanoparticle physics research at TLV University to guiding tours, authoring the book “Travel Medicine,” and even co-founding Israel’s first microbrewery, The Home Brewery.

𝗠𝗲𝗲𝘁 𝗔𝗴𝗻𝗶𝗲𝘀𝘇𝗸𝗮 𝗝𝗮𝗿𝗲𝗰𝗸𝗮 — 𝗖𝗙𝗢 𝗮𝘁 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
With a strong background at the intersection of business, healthcare, and technology, Agnieszka Jarecka brings over a decade of experience in managing complex projects in the life sciences sector. She holds a Master’s degree in Management and Marketing from the University of Łódź, and since 2015 has been leading R&D initiatives in innovative neurotechnologies, particularly in the fields of Alzheimer’s disease and epilepsy.
At Cogniguard, Agnieszka serves as Chief Financial Officer, where she is responsible for financial strategy, CE certification, and implementation of the ISO 13485 quality management system — ensuring that our innovations meet the highest global standards. In the early stages of Cogniguard’s journey, she also acted as Project Manager, building the operational structure and coordinating the company’s first R&D activities.
Her career highlights include co-founding the EU-MED Summit, a conference dedicated to advancing medical technologies, and successfully securing significant EU funding for innovative medtech projects. Before transitioning fully into life sciences, Agnieszka also worked in the renewable energy sector, where she was involved in wind energy projects with Cerac Group. This multidisciplinary perspective allows her to connect ideas across industries and turn them into impactful innovation in medicine.
What motivates her most is combining purpose with structure: transforming complex medical and regulatory challenges into scalable solutions that have long-term social impact.

𝗠𝗲𝗲𝘁 𝗣𝗿𝗼𝗳. 𝗝𝗮𝗻 𝗞𝗼𝗻𝗼𝗽𝗮𝗰𝗸𝗶 — 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝗻𝘁 𝗮𝘁 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
With nearly five decades dedicated to neuroscience, Prof. Jan Konopacki has shaped the field of neurobiology and neuropharmacology of brain oscillatory activity. Since earning his Ph.D. in 1981 and full professorship in 1998, he has supervised over 70 MSc theses, 8 PhD theses, and 4 habilitations, authored more than 100 scientific papers (PubMed: Jan Konopacki), and written the widely used academic handbook Physiology of Animals (2016).
For most of his career, Prof. Konopacki has been affiliated with the University of Łódź, where he also served as Head of the Department of Neurobiology. During his years at the University of Calgary in the late 1980s, he developed a pioneering in vitro technique for inducing and recording EEG theta oscillations in hippocampal slices — a breakthrough that fundamentally changed how researchers study brain activity in vitro.
At Cogniguard, Prof. Konopacki designed the project’s preclinical studies on laboratory animals and now serves as a scientific consultant and adviser to Dr. Adam Broncel.
What excites him most is seeing how decades of preclinical neuroscience research can now directly contribute to clinical studies for patients with dementia and Alzheimer’s disease.
His motivation? Curiosity and the belief that science should make a real difference in people’s lives.

𝗠𝗲𝗲𝘁 𝗪𝗼𝗷𝗰𝗶𝗲𝗰𝗵 𝗕𝗶𝗮𝗹𝗲𝗰𝗸𝗶 — 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿 𝗮𝘁 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
With over eight years of experience in the medical device industry, Wojciech brings a unique blend of technical expertise and creative problem-solving to every project. A graduate of the Lodz University of Technology, specializing in Biomedical Engineering and electronics, Wojciech has contributed to the development of three medical devices and played a hands-on role in two clinical trials conducted in Poland and Israel.
At Cogniguard, Wojciech Białecki works at the intersection of technology, medicine, and patient care — ensuring every element of a project aligns seamlessly to deliver devices that meet the highest standards. For Wojciech, the mission is clear: to advance humanity and improve quality of life, while embracing the challenge of solving complex, multi-layered problems.
Recognized for an unconventional, out-of-the-box approach, Wojciech is often the go-to person for resolving challenges and easing concerns — both within the team and in collaboration with partners.

𝗠𝗲𝗲𝘁 𝗞𝗮𝗿𝗼𝗹𝗶𝗻𝗮 — 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗔𝘀𝘀𝗶𝘀𝘁𝗮𝗻𝘁 𝗮𝘁 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱

With a degree in psychology from the University of Łódź and 18 years of professional experience, Karolina has dedicated her career to psychological assessments and diagnostics. She has worked with children and adults alike, supporting individuals with somatic and mental illnesses as well as physical and intellectual disabilities, always with the goal of improving their quality of life.

At Cogniguard, Karolina serves as Clinical Research Assistant, where she supports the planning and execution of clinical studies. She works closely with research teams, medical professionals, and participants to ensure that data is collected with precision and that every stage of the study meets strict regulatory standards.

What she values most is being part of a mission-driven project — developing innovative technology to support the fight against Alzheimer’s disease and cognitive decline. For Karolina, it is deeply rewarding to see how research today can transform into solutions that make everyday life easier for patients and their families.

Her proudest professional achievement is knowing that, through her knowledge and experience, she can have a tangible impact on people’s ability to function better in daily life.

What motivates her? The chance to make a real difference in people’s lives — helping patients overcome challenges and supporting their independence.

𝗠𝗲𝗲𝘁 𝗘𝘄𝗮 𝗣𝘂ł𝗮𝗰𝘇𝗲𝘄𝘀𝗸𝗮 — 𝗠𝗮𝗿𝗸𝗲𝘁𝗶𝗻𝗴 & 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗮𝘁 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
Ewa Pułaczewska is the creative force behind Cogniguard’s communication and brand presence. With a dual academic background in Sociology and Marketing & Management, and nearly two decades of professional experience, she bridges human insight with strategic thinking. A certified project manager and business trainer, she knows how to combine precision, structure, and creativity to deliver meaningful results.
At Cogniguard, Ewa is responsible for shaping the company’s communication and brand image. She manages content creation, social media, website development, and marketing campaigns — ensuring that our mission and breakthroughs in Alzheimer’s therapy reach the right audiences. Her day-to-day work bridges strategy and creativity, supporting both the company’s growth and its visibility in international markets.
What drives her most is meaningful work with impact: “At Cogniguard, I have the opportunity to contribute to developing innovative therapies for Alzheimer’s disease. Building a brand from the ground up, while collaborating with brilliant experts, is both challenging and rewarding.”
Ewa is especially proud of successfully leading complex R&D and marketing projects, often bringing delayed initiatives back on track and turning them into success stories.

𝗠𝗲𝗲𝘁 𝗝𝗼𝗮𝗻𝗻𝗮 𝗪𝗲𝘁𝗲𝗿𝗹𝗲 — General Administration 𝗠𝗮𝗻𝗮𝗴𝗲𝗿 𝗮𝘁 𝗖𝗼𝗴𝗻𝗶𝗴𝘂𝗮𝗿𝗱
With many years of experience in both international and local organisations, Joanna Weterle brings unmatched expertise in office management and administrative support for research and development projects. Her background includes coordinating EU-funded initiatives, managing project documentation in line with legal and quality standards, and ensuring smooth collaboration with external institutions.

At Cogniguard, Joanna is the backbone of our daily operations. She oversees office organisation, supports our research and development teams, and manages project documentation with precision and care. Her role also includes assisting the Management Board in day-to-day activities and guiding the company through internal and external audits.

What drives her most is the opportunity to contribute her skills to innovative projects that have the potential to transform patients’ lives. Joanna values working in a dynamic, collaborative environment where her organisational talent directly supports Cogniguard’s mission.

Meet Ben Zion Levi — Chief Technical Officer at Cogniguard

With more than 25 years of leadership in medical device innovation, Ben Zion Levi brings deep multidisciplinary expertise to Cogniguard’s mission of transforming the treatment landscape for Alzheimer’s disease. His career spans senior R&D and engineering roles at global med‑tech companies including SmartLight, Syneron Medical, InMode, and Home Skinovations—organizations known for pioneering technologies that have reshaped patient care worldwide.
Ben Zion has led the development of breakthrough systems from concept to commercialization, integrating advanced engineering with clinical insight and rigorous quality standards. His work consistently bridges scientific discovery with real‑world usability, ensuring that complex technologies become safe, effective, and accessible solutions for patients and clinicians.
At Cogniguard, he oversees all research, development, and engineering activities, guiding the creation of next‑generation neurostimulation technologies that are grounded in science and inspired by humanity. His leadership plays a central role in translating cutting‑edge neuroscience into devices designed to preserve memory, restore independence, and improve quality of life for millions of families.
Ben Zion holds a BSc in Electrical and Computer Engineering from the Technion – Israel Institute of Technology.

Dr. Ben-Menachem serves as Director of the Epilepsy and Neuropharmacology Clinical Research Program at Sahlgrenska University Hospital and the Editor-in-Chief of “Acta Neurologica Scandinavica,” She received the 2017 Lifetime Accelerator Award. The award is distributed annually by the Epilepsy Foundation and given to people who have shown a lifelong commitment to obtain new treatments for people living with epilepsy

Psychiatrist and Head of the Department of Adult Psychiatry, Medical University of Lodz. He holds a prestigious position of National consultant in the field of psychiatry in Poland. Author and co-author of over 300 publications, including combining of psychiatry and psychology. Principal Investigator on clinical trials and advisor of R&D process.

Prof. Davidson has published over 350 articles in peer reviewed journals in the area of Psychiatry and of Alzheimer’s disease. Previously he was Department Chairman at the Tel Aviv University and Chief Editor of the European Neuropsy- chopharmacology journal. He is currently Chairman of the department of psychiatry at the Nicosia University medical school, the President of the Alzheimer Center in Israel